Among recipients who have discontinued IS, 10/14 (71%) are broadly sensitized with panel reactive antibody (PRA) >or=50%.

• 在患者停止免疫抑制治疗后，10/14（71%25）的患者广泛致敏，群体反应性抗体（PRA）>=50%25。